1. Smyrk TC, Lynch HT, Watson PA, Appelman HD. Histologic features of hereditary nonpolyposis colorectal carcinoma. In: Utsunomiya J, Lynch HT, eds. Hereditary colorectal cancer. Tokyo: Springer-Verlag, 1990; 357-362 [DOI via Crossref] | | 2. Jang YS, Steinhagen RM, Heimann TM. Colorectal cancer in familial adenomatous polyposis. Dis Col & Rect. 1997; 40:312-316. [DOI via Crossref] | | 3. Campbell AJ, Spence RAJ, Park TG. Familial adenomatous polyposis. Br J Surg. 1994; 81:1722-1733. [DOI via Crossref] [Pubmed] | | 4. Bodmer WF, Bailey CJ, BodmerJ, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328:614-616. [DOI via Crossref] [Pubmed] | | 5. Bisgaard ML, Fenger K, Bulow S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 1994; 3:121-125. [DOI via Crossref] [Pubmed] | | 6. Sarre RG, Frost AG, Jagelman DG, et al. Gastric and duodenal polyps in familial adenomatotis polyposis: a prospective study of the nature and prevalence of tipper gastrointestinal polyps. Gut 1987; 28:306-314. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 7. Giardello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with Sulindac. N Engl J Med 2002; 346:1054-1099. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 8. Steinbach G, Lynch PM, Phillips RKS, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342:1946-1952. [DOI via Crossref] [Pubmed] | |
|
|